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Tyramide signal amplification mass spectrometry
(TSA-MS) ratio identifies nuclear speckle proteins
Joseph Dopie1, Michael J. Sweredoski2, Annie Moradian2, and Andrew S. Belmont1
We present a simple ratio method to infer protein composition within cellular structures using proximity labeling approaches
but compensating for the diffusion of free radicals. We used tyramide signal amplification (TSA) and label-free mass
spectrometry (MS) to compare proteins in nuclear speckles versus centromeres. Our “TSA-MS ratio” approach successfully
identified known nuclear speckle proteins. For example, 96% and 67% of proteins in the top 30 and 100 sorted proteins,
respectively, are known nuclear speckle proteins, including proteins that we validated here as enriched in nuclear speckles. We
show that MFAP1, among the top 20 in our list, forms droplets under certain circumstances and that MFAP1 expression levels
modulate the size, stability, and dynamics of nuclear speckles. Localization of MFAP1 and its binding partner, PRPF38A, in
droplet-like nuclear bodies precedes formation of nuclear speckles during telophase. Our results update older proteomic
studies of nuclear speckles and should provide a useful reference dataset to guide future experimental dissection of nuclear
speckle structure and function.
Introduction
While different cellular compartments and structures have
distinct protein compositions, methods for easily analyzing the
protein composition of these different compartments and how
they vary with changes in cell differentiation or physiology are
limited (Bell et al., 2001; Croze and Morre´, 1984; Mootha et al.,
2003; Taylor et al., 2003). Biochemical purification is frequently
accompanied by loss of specific proteins. Moreover, cellular
bodies and structures that are not surrounded by lipid mem-
branes may lose their physical integrity during biochemical
isolation. Bodies with liquid-like properties are particularly
prone to such disruptions with physical isolation procedures.
For example, previous biochemical purification of inter-
chromatin granule clusters (IGCs), also known as nuclear
speckles, has enriched for individual granules present within
IGCs; the extent to which nongranule components of the IGCs
are lost during purification is unknown (Mintz et al., 1999;
Saitoh et al., 2004).
Enzyme-based proximity labeling methods for tagging and
then purifying the tagged proteins within particular cellular
structures have been developed as an alternative to biochemical
purification. Proximity labeling methods work to label proteins
in situ with the goal of preserving cell structure during labeling.
Thus, proximity labeling approaches are particularly well suited
for enriching proteins within less stable and hard-to-purify
cellular structures. For example, proximity-dependent biotin
identification uses in vivo expression of a biotin ligase, targeted
to a specific cell structure, to biotinylate proteins in the vicinity
of the targeted biotin ligase. The biotin ligase (BirA) is en-
gineered (BirA*) to label proteins “promiscuously,” with current
models suggesting the release of a biotinoyl-59-AMP that dif-
fuses to label nearby proteins (Roux et al., 2012). Engineered
ascorbate peroxidase (APEX) also uses in vivo expression of a
cytoplasmic peroxidase to generate short-lived biotin-phenoxyl
radical, from biotin-phenol, that diffuses to label tyrosines on
nearby proteins. Again, targeting the APEX enzyme to specific
cell structures enables labeling of nearby proteins (Rhee et al.,
2013).
A major unknown for all enzyme-based proximity labeling
approaches is how far the labeling can spread from the targeted
enzyme generating the label. Current estimates point to a radius
of ∼10 nm for biotin identification, which may be too small for
complete labeling coverage of cellular organelles and bodies
(Kim et al., 2014). The literature has cited an APEX staining
radius of ∼20 nm, based on the visualization by electron mi-
croscopy of a polymerized DAB product catalyzed by free radi-
cals produced by APEX (Martell et al., 2012). However, this
reported staining radius is an underestimation as it does not take
into consideration that the DAB product visualized by electron
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microscopy is a precipitant deposited near the site of the
peroxidase.
Tyramide signal amplification (TSA), an older method that
preceded APEX, uses exogenous HRP targeted by immunostaining
to generate tyramide (phenoxyl) radicals (Bobrow et al., 1989, 1991;
van Gijlswijk et al., 1996, 1997). HRP is more active than APEX and
has been used to label proteins in extracellular, oxidizing com-
partments (Loh et al., 2016; Martell et al., 2016) and fixed samples
(Bar et al., 2018). In fact, the staining radius of the HRP-generated
radical, whose concentration decays exponentially from the HRP
source, has been estimated by light microscopy at ∼0.5–1 µm
(Carter et al., 2002; Chen et al., 2018). While the staining radius of
the phenoxyl radical generated by APEX in the living cell has not
been likewisemeasured, it is likely similar. The estimated staining
radius of TSA, and possibly APEX, may exceed the size of some
targeted cell structures.
Here, we describe our application of TSA to the proximity
labeling and proteomic analysis of IGCs/nuclear speckles. Nuclear
speckles are irregularly shaped nuclear bodies that vary in size
and number depending on the cell type (Galganski et al., 2017) and
are thought to form by protein–protein and protein–RNA inter-
actions (Shevtsov and Dundr, 2011). Previously, nuclear speckle
protein composition was characterized biochemically, through
isolation of the individual granules contained within IGCs. Over
80% of the proteins identified in this granule fraction were pro-
teins involved in RNA synthesis and processing (Saitoh et al.,
2004).
We describe a simple but key approach whereby we compare
the relative abundances of proteins identified by TSA labeling of
nuclear speckles versus centromeres. The nuclear speckle en-
richment of each protein was determined based on its relative
abundance in the pull-down fractions from nuclear speckles
versus centromeres after TSA labeling. This approachminimized
nonspecific background and false-positive hits (Mellacheruvu
et al., 2013), producing a list of several hundred proteins as en-
riched in nuclear speckles. The majority of these proteins are
associated with RNA synthesis and/or processing and overlapped
(∼60%) with the proteins identified in the previous proteomic
analysis of isolated IGC granules. Approximately two thirds of the
top 100 sorted proteins have been shown previously by light
microscopy to accumulate in nuclear speckles.
In addition, we validated by light microscopy the nuclear
speckle localization of several proteins, including the pre-mRNA
processing factor microfibrillar-associated protein 1 (MFAP1;
Andersen and Tapon, 2008; Bertram et al., 2017). Interestingly,
MFAP1 levels modulate the size of nuclear speckles and may
contribute to the nucleation of nuclear speckles after mitosis.
Results
Experimental goals and design of the staining approach
We applied TSA (Bobrow et al., 1989; Wang et al., 1999; Fig. 1 A
and Fig. S1 A) proximity labeling of proteins followed by com-
parative MS (mass spectrometry) of multiple cellular compart-
ments, a simple, robust, cost effective, and easily applicable
approach that is suitable for some membrane-less nuclear bod-
ies/compartments. Given that the estimated staining radius of
the TSA reaction is roughly comparable to the size of some
nuclear bodies, we reasoned that proteins identified by TSA
labeling would contain a significant fraction of nonspecific
proteins. To overcome the possibility of enriching and identi-
fying extraneous proteins outside the structure of interest, we
compared the abundance of proteins in a “target” nuclear body/
structure to a “reference” body and tested our approach using
nuclear speckles and centromeres as target and reference bod-
ies, respectively (Fig. 1, A and B).
Nuclear speckles, ranging from ∼0.4 to 2 µm in diameter
(Fakan and Puvion, 1980), are typically depleted from the nu-
clear periphery, enriched in the nuclear interior (Carter et al.,
1991), and surrounded by the A1 Hi-C active chromosomal sub-
compartment (Chen et al., 2018). Centromeres and their flanking
pericentric heterochromatin, on the other hand, are hetero-
chromatic, with a protein composition distinct from the active
chromatin regions surrounding nuclear speckles (Fodor et al.,
2010; Müller-Ott et al., 2014; Obuse et al., 2004). Centromeres
are present throughout the nucleus but nonrandomly associate
with the nuclear periphery and nucleolus (Carvalho et al., 2001).
Therefore, we reasoned that centromeres would be good reference
nuclear body for comparisonwith nuclear speckles. Moreover, both
centromeres (Obuse et al., 2004) and nuclear speckles (Mintz et al.,
1999; Saitoh et al., 2004) have been targets of previous proteomic
analysis, and many proteins have already been validated by mi-
croscopy as enriched in either centromeres or nuclear speckles.
We determined TSA-labeling conditions producing specific
staining of nuclear speckles and centromeres in human U2OS
cells (Fig. 1 B). For the TSA reaction, we modified conditions
developed earlier for TSA sequencing (Chen et al., 2018). Cells
were grown to ∼90% confluency, fixed with PFA, and stained
first with primary antibodies against either SC35 or CENPA
followed by HRP-conjugated secondary antibodies. Next, we
incubated cells with TSA reaction buffer containing tyramide
and H2O2 in PBS. For one replicate, we added sucrose to the TSA
reaction buffer, which slightly reduces the TSA staining radius
(Chen et al., 2018). Initially, we used tyramide conjugated to biotin
for avidin-biotin pull-down. However, Western blotting showed
prominent background bands, likely produced by endogenous
biotinylated proteins. Thus, we replaced biotin-tyramide with
FITC tyramide (Fig. S1, A and B). To further reduce nonspecific
background, we selected antibodies such that the same secondary
antibody is used for both the target and reference structures.
Protein pull-down and MS
We suspended TSA-labeled cells in lysis buffer supplemented
with protease inhibitors and DNase I. Cell clumps were dis-
rupted by passage through a 25G needle, and the cell suspension
was sonicated to obtain a clear lysate. The lysate was centrifuged
to remove cellular debris and FITC proteins were pulled down
using agarose beads conjugated with anti-FITC antibodies. Pro-
teins were eluted off the beads and resolved on polyacrylamide
gel (Fig. 1 C and Fig. S1 C).
To test the TSA labeling and enrichment of labeled proteins,
we examined Western blots probed with antibodies against
FITC (Fig. S1 D) or SON and heterochromatin protein I α (HP1α).
SON and HP1α are highly enriched in nuclear speckles and
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centromeres, respectively. Indeed, the nuclear speckle fraction
was highly enriched with SON and depleted of HP1α, whereas
the centromere fraction was enriched with HP1α and depleted of
SON (Fig. 1 D).
Next, we repeated the TSA labeling and affinity pull-down
but followed this by MS. The relative abundance of each protein
in each of the two nuclear bodies was determined using label-
free quantitation (LFQ; Cox et al., 2014).
Figure 1. TSA-MS ratio. (A) Nuclear speckles or centromeres TSA-MS workflow. Nuclear speckles or centromeres were labeled using TSA with tyramide
coupled to FITC (FITC-tyramide). FITC-labeled proteins were affinity purified and identified using tandem MS. The abundance of each protein in nuclear
speckles or centromeres was estimated using LFQ, and the nuclear speckle versus centromere LFQ ratio for each protein was determined. (B) U2OS cell
showing centromeres or nuclear speckles after combined immunofluorescence and TSA labeling, as indicated, and DNA (blue, DAPI) staining. Boxed areas are
insets shown magnified. Scale bars: main panel, 5 µm; inset, 2 µm. (C) Silver-stained gels after TSA labeling (Input) and affinity pull-down of FITC-labeled
proteins (Pulldown) from nuclear speckles or centromeres. Primary antibodies, including no primary antibody (No1), for TSA labeling are indicated at top of gel.
(D) Western blot comparing SON and HP1α levels in the nuclear speckle and centromere fractions after pull-down of FITC-labeled proteins, as in C. (E and
F) Numbers of the top 100 (E) and top 250 proteins (F), sorted by their nuclear speckle versus centromere (SPK-CEN) ratios, located in nuclear speckles (NS),
nucleoplasm (NP), or cytosol (Cyt). See also Table S1.
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There was an overlap of 1,620–1,870 identified proteins be-
tween paired-replicate nuclear speckle (SC35) TSA-MS experi-
ments (Table S1) and 2,340–2,495 identified proteins between
paired-replicate centromere (CENPA) TSA-MS experiments,
with extensive overlap (60–90%) in the identified proteins from
the combined nuclear speckle and centromere paired datasets
(Table S1). We expected this extensive overlap between cen-
tromere and nuclear speckle identified proteins because of the
large TSA-staining radius. Many overlapping proteins would be
expected to be present in the nucleoplasm surrounding both nu-
clear bodies. Moreover, coimmunostaining revealed that cen-
tromeres and nuclear speckles, while typically spatially separated,
occasionally localized close enough to each other so that their
surrounding TSA-stained volumes would overlap. Additionally,
we expected some proteins would be labeled due to the low-level
nucleoplasmic distribution of CENPA and SC35 proteins outside of
centromeres and nuclear speckles, respectively, as well as non-
specific background primary and/or secondary antibody staining.
To identify candidate nuclear speckle proteins, we calculated
the nuclear speckle versus centromere LFQ intensity ratio for
each protein in each paired dataset (Table S1 and Fig. S2 A). The
geometric mean of these ratios from replicate datasets was then
taken as the nuclear speckle versus centromere (SPK-CEN) ratio.
Only proteins quantified in both the nuclear speckle and paired
centromere pull-down fractions were analyzed. We note that
unique proteins that were quantified in the nuclear speckle, but
not the paired centromere, fractions, including some known
nuclear speckle proteins, were excluded (Table S1).
High percentage of known nuclear speckle proteins among the
top sorted proteins in TSA-MS ratio lists
Our knowledge of nuclear speckle proteins comes from three
main sources. First is the cumulative literature describing mi-
croscopy localization of specific proteins to nuclear speckles.
Second is the previous MS of biochemically fractionated IGC
granules (Mintz et al., 1999; Saitoh et al., 2004). This work
identified 146 proteins, including three proteins (SON, BCLAF1,
and acinus) whose localization previously had been unknown
but that were then validated as enriched in nuclear speckles
using light microscopy (Saitoh et al., 2004; Table 1). Third is the
Human Protein Atlas (HPA) survey of the staining patterns of
thousands of different antibodies (Thul et al., 2017), which in-
cluded a “localized to the nuclear speckles” annotation. Note that
this assignment is based solely on the characteristic staining
pattern observed and not on the actual colocalization of this
staining pattern with a known nuclear speckle marker.
Our analysis also identified proteins previously shown by
light microscopy to be enriched in nuclear speckles. Indeed, the
list of proteins with the highest SPK-CEN ratios showed a very
high percentage of these “validated” nuclear speckle proteins,
with this percentage dropping with decreasing SPK-CEN ratio.
Specifically, 96% of the top 30 sorted proteins are validated as
nuclear speckle proteins, including two proteins that we vali-
dated as localized to nuclear speckles (Table 1). This percentage,
however, drops to 68% for the top 100 sorted proteins and 35%
for the top 250 proteins (Fig. 1, E and F; Table 1; and Table S1).
Roughly one third (23) of these 68 validated nuclear speckle
proteins in the top 100 sorted list, including PRPF4B, LUC7L3,
and CDK12, had not been identified previously in theMS analysis
of isolated IGC granules (Saitoh et al., 2004; Table 1 and Table S1).
Empirically, the SPK-CEN ratio cutoff corresponding to a
nuclear speckle enrichment sufficient for wide-field light
microscopy detection was ∼1.65 (ratio for 91th protein), with
approximately three fourths of the top-sorted 91 proteins pre-
viously identified by light microscopy as nuclear speckle local-
ized. This includes 7 out of the 10 proteins whose SPK-CEN ratio
is equal to or just above this 1.65 ratio cutoff, as compared with
2 of the next 10 proteinswhose ratio is just below this 1.65 cutoff.
The actual level of enrichment in nuclear speckles is likely
several-fold higher. Given the known radius of diffusion of the
tryamide free radical, the actual volume of the tryamide-stained
regions surrounding the centromeres and nuclear speckles should
be several-fold larger than the volumes of the speckles or cen-
tromere regions themselves. Experimentally, SON, with the
highest SPK-CEN ratio of 4.9, appears >10-fold enriched in nuclear
speckles by wide-field deconvolution light microscopy and even
more highly enriched in speckles as observed by super-resolution
light microscopy (Chen et al., 2018; Kim et al., 2019).
Interestingly, the HPA annotates some previously validated
nuclear speckle proteins as “mainly localized to the nucleo-
plasm” (Table 1), including ACIN1 (Saitoh et al., 2004) and SRSF2
(SC35; Fu and Maniatis, 1992), which currently is the most
widely used nuclear speckle marker. Using light microscopy,
we show in a later Results section (Validating potential nuclear
speckle proteins) that three (MFAP1, pre-mRNA processing factor
38A [PRPF38A], and zinc finger 207 [ZNF207]) out of three pro-
teins tested from the top 30 list, whose nuclear speckle localization
had been unknown or ambiguous, were indeed nuclear speckle
enriched. Thus, the true percentage of speckle-enriched proteins
in our top-sorted lists may be significantly higher than the per-
centage of previously validated nuclear speckle proteins.
Annotated functions of top sorted proteins in nuclear
speckle–enriched TSA-MS ratio list
Similar to the findings from the previously published MS study
of isolated IGC granules (Saitoh et al., 2004), a large fraction of
proteins with high SPK-CEN ratio are also implicated in some
aspect of RNA metabolism (Fig. S1, B and C; Table 1; and Table S1).
Specifically, all of the top 30 sorted proteins (Table 1) are implicated
in some aspect of RNA metabolism, including pre-mRNA splicing
(25), poly(A) tail length control and RNA export (3), and tran-
scription (2). Similarly, 90 of the top 100 proteins are functionally
annotated as RNA processing or proteins engaged in transcription
or transcription regulation (Fig. S2 C and Table S1). Moving further
down the list, 186 of the top 250 proteins are involved in RNA
metabolism, including pre-mRNA splicing factors (108), transcrip-
tion (42), cleavage, polyadenylation or mRNA export (17), and other
proteins annotated only as RNA-binding (19; Fig. S2 B and Table S1).
Structurally, nuclear speckles behave as liquid-droplet type
bodies (Marzahn et al., 2016) and are thought to form through
multivalent interactions between low-complexity domains
(LCD) on multiple proteins as well as RNA–protein interactions.
Most of the proteins with higher SPK-CEN ratio contain RNA-
binding domains and/or LCDs (Table 1 and Table S1). One such
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Table 1. List of the top 52 proteins sorted by SPK-CEN ratio
# Gene
name
Entry ID SPK-CEN
ratio
Protein domains GO annotated
process
Localization
(IF)
IF references
1 SON P18583 4.918 LCD, DRBM, G patch Splicing NS HPA, Saitoh et al. (2004)
2 SRRM2 Q9UQ35 4.642 LCD, coiled coil Splicing NS HPA, Mintz et al. (1999)
3 PRPF40A O75400 3.050 LCD, coiled coil, WW Splicing NS HPA
4 RBM25 P49756 2.722 LCD, RRM, coiled coil, PWI Splicing NS HPA, Zhou et al. (2008)
5 ZNF207 O43670 2.564 LCD, ZnF Transcription NS Rai et al. (2018), this study
6 LUC7L2 Q9Y383 2.413 LCD, coiled coil Splicing NS Howell et al. (2007)
7 SRRM1 Q8IYB3 2.409 LCD, PWI Splicing NS HPA
8 WTAP Q15007 2.373 LCD, coiled coil Splicing NS HPA, Little et al. (2000)
9 ZC3H14 Q6PJT7 2.362 LCD, ZnF Poly(A) binding NS HPA, Leung et al. (2009)
10 ACIN1 Q9UKV3 2.341 LCD, coiled coil, RRM, SAP Splicing NS Saitoh et al. (2004)
11 SAP18 O00422 2.328 LCD Splicing NS Singh et al. (2010)
12 DDX46 Q7L014 2.299 LCD, DEXD, HELICc Splicing NS HPA, Will et al. (2002)
13 TRA2A Q13595 2.295 LCD, RRM Splicing NS Platt et al. (2015)
14 SRSF2 Q01130 2.284 LCD, RRM Splicing NS Fu and Maniatis (1990)
15 DDX23 Q9BUQ8 2.263 LCD, coiled coil, DEXDc,
HELICc
Splicing NP HPA
16 CDK12 Q9NYV4 2.247 LCD, S_TKc Transcription NS Ko et al. (2001)
17 PRPF4B Q13523 2.239 LCD, coiled coil Splicing NS HPA
18 LUC7L3 O95232 2.238 LCD, coiled coil Splicing NS HPA, Umehara et al. (2003)
19 MFAP1 P55081 2.230 LCD, coiled coil Splicing NS This study, Salas-Armenteros et al.
(2019)
20 SF3A1 Q07955 2.227 LCD, RRM Splicing NS HPA, Huang et al. (2011)
21 SF3B2 Q13435 2.205 LCD, coiled coil Splicing NS HPA, Terada and Yasuda (2006)
22 RBM39 Q14498 2.200 LCD, RRM Splicing NS HPA, Imai et al. (1993)
23 RBM10 P98175 2.181 LCD, RRM, ZnF, G patch Splicing NS HPA, Inoue et al. (2008)
24 SRSF1 Q07955 2.137 LCD, RRM Splicing NS Ca´ceres et al. (1997)
25 RBM26 Q5T8P6 2.123 LCD, ZnF, RRM, coiled coil RNA binding NS HPA
26 SF3A3 Q12874 2.077 LCD, ZnF, coiled coil Splicing NS Chiara et al. (1994)
27 RBM8A Q9Y5S9 2.074 LCD, RRM Splicing NS HPA
28 RBM27 Q9P2N5 2.062 LCD, RRM RNA binding NS HPA
29 PRPF38A Q8NAV1 2.048 LCD, coiled coil Splicing NS This study
30 SNRPA1 P09661 2.038 LCD, LRRcap Splicing NS HPA
31 PUF60 Q9UHX1 2.030 LCD, RRM Splicing NP HPA
32 SAP30BP Q9UHR5 1.998 LCD Transcription NP Li et al. (2004)
33 PRPF6 O94906 1.996 LCD, coiled coil, HAT Splicing NS HPA
34 RNPS1 Q15287 1.993 LCD, RRM Splicing NS Trembley et al. (2005)
35 AURKA O14965 1.982 S_TKc Kinase NP HPA
36 RBM17 Q96I25 1.979 LCD, G patch, RRM Splicing NP HPA
37 LSM3 P57743 1.948 Sm Splicing NP HPA
38 SF3B1 O75533 1.946 LCD, coiled coil Splicing NS HPA
39 RPRD1B Q9NQG5 1.942 RPR, coiled coil Transcription NP HPA
40 CAPRIN1 Q14444 1.931 LCD, coiled coil RNA-binding Cy Solomon et al. (2007)
41 PRPF4 O43172 1.931 LCD, SFM, WD40 Splicing NS HPA
42 CDC5L Q99459 1.915 LCD, SANT, coiled coil Splicing NS Burns et al. (1999)
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highly disordered protein, ZNF207/BuGZ, has been previously
demonstrated to undergo phase transition to form liquid drop-
lets as part of the mitotic spindle apparatus (Jiang et al., 2015).
Sorting proteins enriched in centromeres
Sorting proteins instead by the magnitude of the centromere
versus nuclear speckle (CEN-SPK) ratio creates a list of potential
centromere-enriched proteins, analogous to the previously de-
fined nuclear speckle–enriched list (Fig. 1 A). However, in con-
trast to the significant enrichment of known nuclear speckle
proteins among proteins with high SPK-CEN ratio, our list of
proteins with high CEN-SPK ratio was dominated by proteins
that localized to the nucleolus, nucleoplasm, or cytoplasm (Table
S1). Of the top 100 proteins sorted by the CEN-SPK ratio, 50 are
nucleolar proteins, while HP1α (Kang et al., 2011) and Aurora B
kinase (Yamagishi et al., 2010) were the only well-characterized
heterochromatin and/or centromere-associated proteins (Table S1).
This small number of validated centromere or heterochro-
matin proteins in our CEN-SPK ratio–sorted list does not appear
to be a problem with the centromere TSA labeling and/or pull-
down. Rather, many known centromere- and heterochromatin-
associated proteins were present in the replicate centromere
TSA-MS datasets but had no LFQ intensities in the paired nu-
clear speckle TSA-MS datasets (Table S1), including 10 CENP
proteins (CENPC, CENPB, CENPH, CENPK, CENPT, CENPN,
CENPI, CENPO, CENPP, and CENPX; Obuse et al., 2004;
Verdaasdonk and Bloom, 2011), HMGA2 (Narita et al., 2006), and
HDAC1 (Yamada et al., 2005; Table S1).
We chose centromeres as the reference nuclear body for our
ratio approach, because we expected centromere labeling would
include proteins present throughout the nucleoplasm, but not
proteins enriched within or near nuclear speckles. Centromeres
nonrandomly localize close to nucleoli and the nuclear periph-
ery, which are regions not typically associated with nuclear
speckles. Moreover, centromeres are smaller than the diffu-
sion radius of the tyramide radical, allowing significant la-
beling of the proteins in the surrounding nucleoplasm. Future
application of the TSA-MS ratio to identify proteins specifi-
cally enriched in centromeres and other heterochromatin
regions might benefit from a different reference target.
Here, we focused our attention and further validation work
on nuclear speckle–enriched proteins.
Validating potential nuclear speckle proteins
As described, many of the top sorted proteins in our SPK-CEN
ratio list are previously validated nuclear speckle proteins
(Table 1 and Table S1). However, the top-sorted lists also in-
cluded proteins for which conflicting data previously existed
with regard to their nuclear speckle localization, proteins pre-
viously identified as not enriched in speckles, or proteins with
no information available regarding their possible nuclear
speckle localization. Some proteins with high SPK-CEN ratio
could be proteins specifically depleted from centromeres and the
surrounding nucleoplasm rather than enriched within nuclear
speckles (false positives). Other proteins with a high SPK-CEN
ratio could be specifically enriched in nuclear speckles but have
not been examined previously by microscopy or have incor-
rectly appeared not to be enriched in nuclear speckles due to
some technical problem (false negatives).
Therefore, we investigated the nuclear speckle localization of
3 proteins among the top 30 sorted protein list: MFAP1,
PRPF38A, and ZNF207. Both MFAP1 and PRPF38A are compo-
nents of the spliceosome (Agafonov et al., 2011; Bertram et al.,
2017). They are implicated in pre-mRNA splicing (Andersen and
Tapon, 2008) but are annotated as “localized to the nucleo-
plasm” by the HPA. ZNF207, also known as BUGZ, is a kineto-
chore and microtubule-binding protein (Jiang et al., 2015)
recently shown to accumulate in nuclear speckles of preextracted
Table 1. List of the top 52 proteins sorted by SPK-CEN ratio (Continued)
# Gene
name
Entry ID SPK-CEN
ratio
Protein domains GO annotated
process
Localization
(IF)
IF references
43 SRSF7 Q16629 1.909 LCD Splicing NP HPA
44 PRPF8 Q6P2Q9 1.906 LCD, RRM, ZnF Splicing NS Malinova´ et al. (2017)
45 SNW1 Q13573 1.906 LCD Splicing NP HPA, Zhang et al. (2003)
46 DHX15 O43143 1.886 LCD, DEXDc, HELICc Splicing NS HPA
47 XAB2 Q9HCS7 1.882 LCD, HAT Splicing NP HPA, Onyango et al. (2016)
48 TLE3 Q04726 1.877 LCD, WD40, coiled coil Transcription NP HPA
49 KIAA1429 Q69YN4 1.876 LCD Splicing NS Horiuchi et al. (2013)
50 CHERP Q8IWX8 1.867 LCD, G_patch, SWAP Splicing NS Sasaki-Osugi et al. (2013)
51 SART1 O43290 1.865 LCD, coiled coil Splicing NS HPA
52 PSME3 P61289 1.859 Misc. NS Baldin et al. (2008)
Also displayed are the annotated protein domains, GO Modular Architecture Research Tool SMART, HPA, the UniProt knowledgebase (https://www.uniprot.
org/), as well as available literature. IF (immunofluorescence or fluorescent protein signal); FDEXD (DExD/H-box helicase domain); DEXDc (DEAD-like helicases
superfamily); HELICc (helicase superfamily c-terminal domain); HAT (Half-A-TPR repeats); DRBM (double-stranded RNA-binding motif); LRRcap (LRR-
containing proteins); ZnF (zinc finger); S_TKc (Serine/Threonine protein kinases, catalytic domain). NP, nucleoplasm; NS, nuclear speckle,
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cells (Rai et al., 2018) but annotated as “localized to the nucleo-
plasm” by the HPA.
Coimmunofluorescence staining using antibodies against
MFAP1 or ZNF207 and antibody for SC35, to visualize nuclear
speckles, showed nuclear speckle accumulation for both pro-
teins in cells fixed with methanol (Fig. 2 A). Formaldehyde-fixed
cells instead showed diffuse foci throughout the nucleoplasm
(Fig. S2 D). However, recent reinvestigation of mitotic book-
marking revealed a large number of transcription factors that
appear to lose their DNA binding during mitosis, as visualized
after formaldehyde fixation, in fact show strong mitotic chromo-
some localization in live cells using fluorescently tagged protein
expression. Live-cell imaging revealed a loss of transcription fac-
tor within seconds of adding formaldehyde (Teves et al., 2016).
To distinguish between these possibilities and to validate
nuclear speckle localization of these proteins, we transfected
cells to express human MFAP1, PRPF38A, or ZNF207 proteins
fused to GFP. GFP-MFAP1– or GFP-PRPF38A–expressing cells
showed GFP accumulation in nuclear speckles after formalde-
hyde fixation (Fig. 2, B–D). Therefore, the apparent loss of nu-
clear speckle staining for these proteins likely reflects the
sensitivity of their antibody epitopes to formaldehyde fixation.
However, cells transiently transfected with GFP-ZNF207 and
fixed with formaldehyde still showed diffuse nucleoplasm
staining, similar to immunostaining of the endogenous ZNF207
protein (Fig. S2 E). Live-cell microscopy, however, showed GFP-
ZNF207 colocalized with SON in nuclear speckles (Fig. 2 E).
This sensitivity of either antibody epitope preservation or
protein nuclear speckle localization to formaldehyde fixation
conditions (with or without preextraction) may account for
previous negative or conflicting results for nuclear speckle lo-
calization for these three proteins. We note that while this
Figure 2. Microscopy validation of proteins with a high SPK-CEN ratio. (A) Nuclear speckle localization (SC35, red) of MFAP1 or ZNF207 (green) in U2OS
after immunostaining of methanol-fixed cells (but not after formaldehyde fixation; see Fig. S2 D). DNA (DAPI), blue. (B and C) Nuclear speckle (SC35 im-
munostaining, red) localization of GFP-MFAP1 and GFP-PRPF38A (GFP-PR38A) after formaldehyde fixation at lower transgene expression levels (upper panel).
At higher expression levels (lower panel), GFP-MFAP1 and GFP-PR38A increasingly form droplet-like bodies outside but frequently adjacent to nuclear
speckles. (C) Arrowhead points to nucleus with lower GFP-PR38A expression and only nuclear speckle staining; arrow points to nucleus with high GFP-PR38A
expression. Insets are magnifications of boxed areas. (D) Colocalization of tagRFP-MFAP1 (red) and GFP-PRPF38A (green) in nuclear speckles (SON im-
munostaining, magenta) and bodies outside of speckles in cells fixed with formaldehyde. (E) GFP-ZNF207 (green) localizes in nuclear speckles (Cherry-SON,
red) in live cells (but not after formaldehyde fixation; see Fig. S2 E). Scale bars: main panel, 10 µm; inset, 2 µm.
Dopie et al. Journal of Cell Biology 7 of 18
Quantitative nuclear speckle proteome using TSA-MS ratio https://doi.org/10.1083/jcb.201910207
D
ow
nloaded from
 https://rupress.org/jcb/article-pdf/219/9/e201910207/1046778/jcb_201910207.pdf by C
alifornia Institute O
f Technology user on 01 July 2020
article was in preparation, MFAP1 was localized to nuclear
speckles using the sequential combination of preextraction,
formaldehyde fixation, and then ethanol fixation (Salas-
Armenteros et al., 2019).
In addition to localizing within nuclear speckles, at high ex-
pression levels, both GFP-MFAP1 and GFP-PRPF38A also formed
bright and distinct, intranuclear, round foci, which scored
negative for both SC35 and SON nuclear speckle markers after
immunostaining (Fig. 2, B–D). Some of these foci were adjacent
to but distinct from nuclear speckles. Foci were absent in cells
expressing lower levels of GFP-MFAP1 or GFP-PRPF38A (Fig. 2
C, arrowhead) but increased in number with increasing GFP-
MFAP1 or GFP-PRPF38A expression (Fig. 2 C, arrow; Fig. 2 D),
suggesting foci form as a result of overexpression.
Coexpression of MFAP1 and PRPF38A at higher expression
levels revealed both proteins colocalized in nuclear speckles and
the foci outside of and adjacent to nuclear speckles (Fig. 2 D).
MFAP1 depletion increases nuclear speckle size
Proteins containing arginine/serine (RS) dinucleotide repeats,
including members of the serine/arginine (SR) superfamily of
pre-mRNA splicing factors, are typically enriched in nuclear
speckles (Galganski et al., 2017) and comprise a large fraction of
proteins with high SPK-CEN ratio (Table 1). SON, the protein
with the highest SPK-CEN ratio (Table 1), is a very large, mul-
tidomain protein with a double-stranded RNA-binding domain,
a RS repeat domain, and multiple tandem repeats; all of these
domains could influence nuclear speckle composition and
physical properties. Depleting SON changed nuclear speckle
shape from a solid to doughnut shape and reduced the concen-
tration of U1-70K snRNP and SF2/ASF proteins within nuclear
speckles (Sharma et al., 2010).
We asked whether other proteins, especially non-SR proteins
in the top 30 SPK-CEN ratio–sorted list, might also regulate
nuclear speckle structure (Table 1). SRRM2, number 2 on this
list, is also a large, SR-related protein that has many RS repeats
(Wu and Maniatis, 1993) but lacks an RNA recognition motif
(RRM) that is found in SR proteins (Long and Caceres, 2009),
suggesting SRRM2 may interact with RNA in the presence of
other SR proteins (Blencowe et al., 2000). SRRM2 knockdown
(KD) by siRNA produced no observable change in nuclear speckle
shape or size (Fig. S3, A and D). However, SRRM2 KD reduced the
nuclear speckle association of SC35, but not SON, as visualized by
immunostaining (Fig. S3 E), suggesting that SC35 also is not re-
quired for maintaining normal nuclear speckle size and shape.
ZNF207 undergoes phase transition to form liquid droplets
that promote microtubule polymerization (Jiang et al., 2015).
While ZNF207 has a high nuclear speckle enrichment (Rai et al.,
2018; Fig. 2, A and E), it lacks both an RS domain and an RRM.
Nuclear speckle morphology, and the nuclear speckle localiza-
tion of SC35 and SON, were unchanged in ZNF207-depleted cells
(Fig. S3, A and D).
In contrast, nuclear speckles became noticeably enlarged
after MFAP1 KD (Fig. 3 B and Fig. S3 F). The average nuclear
speckle in a typical MFAP1-depleted cell was ∼3 µm along its
widest length (maximum length, ∼5 µm), as compared with
typical, ∼0.5–2 µm lengths in control cells (Fig. S3 D; and Fig. 3,
B and C). MFAP1 depletion also increased nuclear speckle size in
nontransformed human hTERT-immortalized Tig3 fibroblasts
(Fig. S3, B and F) and CHO cells (Fig. S3, C and G). In CHO cells,
MFAP1 depletion also increased SON nucleoplasmic levels (Fig.
S3 G). We did not observe increased nuclear speckle roundness
after MFAP1 KD (Fig. S3 D and Fig. 3 B).
Some nuclear speckles in MFAP1 KD cells migrated and en-
circled the periphery of nucleoli after RNA polymerase II (RNA
pol II) transcription inhibition (Fig. 3, D–F; and Video 1). Longer
exposure of MFAP1-depleted cells to α-amanitin resulted in
unusually large and fewer nuclear speckles per cell (five or
fewer nuclear speckles in some cells), which sometimes sur-
rounded remnants of nucleoli (Fig. 3 E). In contrast, KD of
PRPF38A, which directly binds MFAP1 (Bertram et al., 2017;
Ulrich et al., 2016), had no effect on nuclear speckle morphology
(Fig. S3, A and D). These observations suggest that normal levels
of MFAP1 are required to both maintain smaller nuclear speckle
size and stabilize nuclear speckle interactionswith other nuclear
structures such as active chromatin.
MFAP1 and PRPF38A partially separate from nuclear speckles
into adjacent bodies after transcriptional inhibition
Overexpression of GFP-MFAP1 results in nuclear foci separate
from and adjacent to nuclear speckles. In some GFP-
MFAP1–overexpressing cells, nearly all GFP-MFAP1 is seques-
tered into the adjacent foci, with undetectable GFP-MFAP1
within the neighboring nuclear speckle (Fig. 2 B). RNA pol II
transcription inhibition increases nuclear speckle size and
roundness (Galganski et al., 2017). Furthermore, previous FRAP
experiments showed that ASF/SF2 association with nuclear
speckles depended on RNA pol II transcription (Kruhlak et al.,
2000; Phair and Misteli, 2000). We therefore examined the
association of GFP-MFAP1 to nuclear speckles after RNA pol II
transcription inhibition.
As expected, inhibiting RNA pol II transcription caused nu-
clear speckles to become rounder but also caused fluorescently
tagged MFAP1 and/or PRPF38A to partially segregate out of
nuclear speckles into foci next to nuclear speckles (Fig. 4, A–D;
Fig. S4 A; and Video 2). SON was undetectable in the adjacent
MFAP1/PRPF38A foci, as visualized by anti-SON immunostaining
(Fig. 4, B and C). The MFAP1/PRPF38A foci that form following
transcriptional inhibition are similar in shape and size to the foci
observed in GFP-MFAP1– or GFP-PRPF38A–overexpressing cells
(Fig. 2, B–D).
Live-cell imaging revealed that these GFP-MFAP1 and GFP-
PRPF38A foci that form next to nuclear speckles after RNA pol II
transcriptional inhibition are dynamic, disappearing within 1 h
following release of the transcription block (Fig. 4, E and F).
Their disappearance coincides with the reaccumulation of GFP-
MFAP1 or GFP-PRPF38A inside nuclear speckles and restoration
of the normal nuclear speckle shape (Fig. 4, E and F; Video 3; and
Video 4).
Nuclear entry of MFAP1 and formation of nuclear foci
precedes complete nuclear speckle reformation in early G1
Given MFAP1’s possible role in maintaining normal nuclear
speckle size, we next investigated the temporal localization of
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MFAP1 during mitosis when nuclear speckles first disassemble
and then reform.
Nuclear speckles disassemble after initiation of mitosis and
their components diffuse throughout the dividing cell (Ferreira
et al., 1994). In late metaphase, some nuclear speckle compo-
nents begin to aggregate into cytoplasmic “mitotic inter-
chromatin granules” (MIGs). MIGs increase in size and number
as cells progress into telophase (Ferreira et al., 1994; Prasanth
et al., 2003). During late telophase, MIGs then disassemble, and
their components are sequentially imported into the nucleus to
form nuclear speckles (Prasanth et al., 2003).
We compared GFP-MFAP1 localization versus SON or SC35
immunostaining during these mitotic events. GFP-MFAP1 dif-
fusely localized throughout the cell following initiation of mi-
tosis. In telophase cells, GFP-MFAP1 was mainly concentrated
within the nuclei, while SON and SC35 remained within
cytoplasmic MIGs (Fig. 5, A and B). Before nuclear speckles re-
formed, as assayed by SON or SC35 localization, GFP-MFAP1 was
present both diffusely throughout the nucleus and also con-
centrated in many small, distinct, round foci that did not stain
for either SON or SC35 (Fig. 5, A and B; and Fig. S4 B). Similar
nuclear foci were observed in telophase cells expressing GFP-
PRPF38A (Fig. 5 C). These GFP-MFAP1 foci showed no coilin
staining (Fig. 5 D); therefore, they do not correspond to mitotic
coiled bodies (Ferreira et al., 1994). However, their appearance
and distribution resemble previous reports of the redistribution
of U-snRNPs during mitosis in PtK2 rat kangaroo cells (Spector
and Smith, 1986).
We next compared MFAP1 and SON dynamics in live cells
during progression through mitosis into early G1. Both GFP-
MFAP1 and mCherry-SON became diffusely localized through-
out the cytoplasm upon the start of mitosis (Fig. 5 E, Video 5, and
Figure 3. MFAP1 KD increases nuclear speckle size and changes nuclear distribution of nuclear speckle proteins after transcriptional inhibition.
(A)Western blot showing (top) KD of endogenous MFAP1 protein after siRNA treatment against MFAP1 (siMFAP1) versus control siRNA (siCTRL) in U2OS cells.
Tubulin (bottom) is the loading control. (B) SON immunostaining (green) in U2OS cells transfected with siCTRL or siMFAP1. DNA (DAPI) is shown in blue. Boxed
areas are magnified on the right. Box plots show nuclear speckle sizes after siMFAP1 versus siCTRL (n = 80 from three independent experiments t test; ***, P <
0.0001). (C) Schematic depicting increased nuclear speckle size with MFAP1 KD followed by rounding of nuclear speckles after transcriptional inhibition but
with redistribution to nucleolar periphery. (D and E) SON (green) and nucleophosmin (Nuc; red) immunostaining with DNA (DAPI, blue) counterstaining of
U2OS cells transfected with siCTRL (top) or siMFAP1 (bottom) 48 h before DRB treatment for 2 h (D) or α-amanitin (α-ama) overnight treatment (E). Boxed
areas in D are magnified on the right. (F) Video stills (Video 1) showing nuclear speckles after addition of DRB to inhibit transcription in MFAP1 KD (siMFAP1)
U2OS cells (top of each panel, time in minutes). Arrows (top) indicate nuclear speckle accumulating around nucleolar periphery. Bottom arrows show a larger
nuclear speckle merging with nucleolar periphery. Nuclear speckles were visualized with GFP-ZNF207. Scale bars: main panel, 10 µm; inset, 5 µm.
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Video 6). In late anaphase and early telophase, when mCherry-
SON was mainly present in cytoplasmic MIGs, GFP-MFAP1 al-
ready was rapidly accumulating in the reforming nucleus (Fig. 5
E and Video 5). This nuclear accumulation of GFP-MFAP1, last-
ing ∼5 min, was then followed by the formation of distinct
nuclear foci (Video 5 and Video 6). Formation of GFP-MFAP1
nuclear foci was followed by the gradual reduction in the size
and number of cytoplasmic MIGs and the increasing colocali-
zation of GFP-MFAP1 and mCherry-SON (Fig. 5 E and Video 5).
These results are consistent with previous reports of the se-
quential entry of nuclear speckle components into the nucleus
after mitosis (Prasanth et al., 2003) but show that formation of
MFAP1 foci precedes the start of nuclear speckle assembly
(Fig. 5). However, our current temporal and spatial resolution
Figure 4. MFAP1 and PRPF38A segregate out of nuclear speckles and into droplet-like bodies adjacent to nuclear speckles after RNA pol II tran-
scription inhibition. (A) Schematic depicting MFAP1/PRPF38A (green) before and after treatment with the RNA pol II transcription inhibitor DRB. (B and
C) Maximum-intensity projections of optical sections of U2OS cells expressing GFP-MFAP1 (B) or GFP-PRPF38A (C, green; GFP-PR38A) treated with either
DMSO (top panels) or DRB (bottom panels) for 2 h. Nuclear speckles (red, SON immunostaining) and DNA (blue, DAPI staining) are shown. Insets are
magnifications of boxed areas. (D) SON immunostaining (magenta) of U2OS cells coexpressing GFP-PRPF38A (GFP-PR38A) and tagRFP-MFAP1 (RFP-MFAP1)
treated with either DMSO or DRB. Boxed areas show magnified views (right panels). (E and F) Recovery of GFP-MFAP1 (E, green; Video 3) or GFP-PRPF38A (F,
green; Video 4) back into nuclear speckles after release from DRB inhibition. Live cell imaging of U2OS cells coexpressing mCherry-SON after 2-h DRB
treatment followed by rinsing with fresh growth media (t = 0). Times (1–45 min) are shown in the top left corner. Boxed areas are magnified (top panels) in
grayscale. Scale bars: main panel, 10 µm; inset, 2 µm.
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Figure 5. MFAP1 and PRPF38A nuclear foci appear after mitosis, before nuclear speckle reassembly. (A and B)Maximum-intensity projections of U2OS
telophase daughter cells expressing GFP-MFAP1 (green) and immunostained with either anti-SC35 (A) or anti-SON (B) antibodies (red) to mark nuclear
speckles. (C) Maximum-intensity projections of U2OS telophase daughter cells expressing GFP-PRPF38A (GFP-PR38A, green) and immunostained with anti-
SON antibody (red). DNA (DAPI) is shown in blue (A–C). (D) Optical section showing U2OS telophase daughter cells expressing GFP-MFAP1 (green) and
coimmunostained with antibodies for coilin (red) and SON (blue). Boxed areas are magnified (right panels). (E) Live-cell imaging (Video 5) of telophase U2OS
cells coexpressing mCherry-SON (red) and GFP-MFAP1 (green) showing nuclear entry and formation of MFAP1 foci while SON is still present in cytoplasmic
foci. Time (inminutes) after start of mitosis is shown in the top left corners. Boxed areas are magnified (top panels) in grayscale. Scale bars: main panels, 10 µm;
insets, 2 µm.
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does not allow us to determine whether MFAP1 foci might di-
rectly nucleate the reformation of nuclear speckles.
Discussion
To identify proteins within a specific cellular structure, we com-
bined the TSA proximity-labeling method with a simple ratio ap-
proach comparing target and reference cell structures. TSA
proximity labeling was followed by affinity pull-down and quanti-
tative MS. This TSA-MS ratio approach compensates for the large
diffusion radius of the label-generating free radical, resulting in la-
beling of many proteins located outside the target cell structure, and
allows for the sorting of candidate proteins with a high likelihood of
localizing within the target cell structure. We applied TSA-MS ratio
to identify proteins enriched in nuclear speckles, using nuclear
speckles as the target and centromeres as the reference structures.
Peroxidase-based proximity-labeling methods rely on the
diffusion of enzyme-generated free radicals to label proteins.
Thus, extraneous proteins may represent a significant fraction
of labeled proteins due to the staining radius of the free radical
relative to the size of the target structures. For example, the
∼1 µm (Chen et al., 2018) estimated staining radius of HRP-
generated biotin-tyramide is relatively large and, in the case of
centromeres, could overlap with some nuclear speckles. To
minimize false positives resulting from this extended TSA la-
beling radius, we compared the relative abundance of proteins
in the nuclear speckles versus centromere pull-down fractions.
This comparison resulted in a significant enrichment of
validated nuclear speckle proteins among the top proteins sorted
by their SPK-CEN ratio. Specifically, 29 out of the top 30 and 67
out of the top 100 sorted proteins localized to nuclear speckles
based on light microscopy. This includes three proteins (MFAP1,
PRPF38A, and ZNF207), for which conflicting data existed pre-
viously, that we validated here as localized to nuclear speckles
using a combination of different fixation conditions and live-cell
imaging. The true percentage of nuclear speckle proteins may be
even higher, as we demonstrated that formaldehyde fixation
perturbs apparent nuclear speckle localization. The percentage
of validated nuclear speckle proteins, however, dropped rapidly
as the SPK-CEN ratio further decreased.
In contrast, the list of proteins with high centromere ratio
(CEN-SPK ratio) was dominated by annotated nucleolar and
cytoplasmic proteins. However, this is consistent with the esti-
mated TSA staining radius (Chen et al., 2018) and the observed
localization of centromeres adjacent to the nucleolar and nuclear
periphery (Carvalho et al., 2001). Centromere and pericentric
heterochromatin proteins were present in this sorted list, but
they showed lower CEN-SPK ratios than the nucleolar and cy-
toplasmic contaminants; other centromeric and pericentric
heterochromatin proteins were only present in the centromere
pull-down fractions.
Thus, the different performance of the ratio sorting approach
for identifying the relative enrichment of proteins in centro-
mere versus nuclear speckle pull-down fractions can be ex-
plained by the TSA staining radius and the size and location of
the centromere and nuclear speckle target bodies. While cen-
tromeres were a good reference structure to eliminate false
positives corresponding to nucleoplasmic proteins surrounding
both centromeres and nuclear speckles, nuclear speckles were
not a suitable reference structure to identify proteins enriched
in centromeres. Future applications of TSA-MS ratio will need to
use these concepts to select suitably matched target and refer-
ence compartments. Previously, we showed that the tyramide
free radical–staining radius can be reduced by varying the TSA-
staining conditions (Chen et al., 2018). We anticipate that future
use of conditions resulting in reduced free radical spreading
should further improve TSA-MS ratio results.
Our analysis identified many known nuclear speckle proteins
that were absent in the isolated IGC granule proteome (Saitoh
et al., 2004), including 20 among the 67 validated nuclear
speckle proteins in the top 100 sorted list. Perhapsmany of these
proteins detected by our approach that were not in the IGC
granule proteome correspond to nuclear speckle proteins that
are not IGC granule components or granule components that are
lost during the IGC granule fractionation procedure.
Consistent with previous work (Saitoh et al., 2004), the
majority of the top SPK-CEN ratio–sorted proteins are involved
in RNA synthesis or processing (Saitoh et al., 2004). The fraction
of proteins involved in RNA metabolism remains high with
decreasing SPK-CEN ratio, even while the percentage of vali-
dated nuclear speckle proteins falls off sharply after the top 100
sorted proteins. Proteins with low SPK-CEN ratio may have fast
on/off rates of nuclear speckle association, reducing their
speckle concentration during the slow formaldehyde fixation.
Thus, the true nuclear speckle concentration of such proteins
may be higher if visualized using other fixation methods or live-
cell imaging (Teves et al., 2016), as we demonstrated for ZNF207.
Proteins with lower SPK-CEN ratio might also correspond to
proteins enriched in regions surrounding nuclear speckles
rather than inside the speckles themselves. A last possibility is
that these proteins might associate with tyramide-labeled pro-
teins after cell lysis and during pull-down.
Nuclear speckles are now thought to form through liquid–
liquid phase separation mediated by protein–protein and
protein–RNA interactions (Galganski et al., 2017). Proteins
containing low-complexity disordered domains readily form
liquid-like bodies both in vivo and in vitro (Altmeyer et al., 2015;
Jiang et al., 2015; Patel et al., 2015). However, pure liquid-phase
separated bodies should be perfectly round, unlike the shape of
nuclear speckles in nonperturbed cells. What nuclear speckle
components might contribute to these deviations from a pure
liquid-like behavior, conferring nonround shape and nonliquid-
like behavior to nuclear speckles, are currently unknown.
Here, we identified MFAP1 as a possible regulator of nuclear
speckle size and anchoring of nuclear speckles to chromatin.
Specifically, we demonstrated enlargement of nuclear speckles
after MFAP1 KD. Conversely, after transcription inhibition both
MFAP1 and PRPF38A partially segregate into dynamic foci next
to nuclear speckles, with this segregation correlating with the
rounding of nuclear speckles generally seen after transcription
inhibition (Galganski et al., 2017). Combining RNA pol II tran-
scription inhibition with MFAP1-KD cells caused fusion of some
nuclear speckles into fewer and larger nuclear speckles, as well
as nuclear speckle fusion with the nucleolar periphery.
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Finally, MFAP1, possibly with PRPF38A, forms nuclear bodies
distinct from nuclear speckles. When overexpressed, both
MFAP1 and PRPF38A segregate out of nuclear speckles, forming
round nuclear bodies in the nucleoplasm distinct from nuclear
speckles, defined by either SC35 or SON staining. As described
in the previous paragraph, transcriptional inhibition also causes
MFAP1 and PRPF38A to segregate out of but adjacent to nuclear
speckles. Interestingly, both MFAP1 and PRPF38A reenter telo-
phase nuclei before import of other nuclear speckle markers
such as SC35 and SON. In these early telophase nuclei, MFAP1
and PRPF38A then condense to form round nuclear bodies
similar in size and shape to those observed after either over-
expression or transcriptional inhibition. Future experiments will
be needed to test what other nuclear speckle proteins cosegregate
within these MFAP1/PRPF38A bodies and whether they may ac-
tually nucleate the reformation of nuclear speckles after mitosis.
In summary, comparing the proteomes of multiple subcel-
lular structures within the crowded nucleoplasm allows im-
proved identification of proteins in different membrane-less
cellular compartments. Furthermore, combining proximity-
labeling methods with different effective staining radii should
allow the probing of different size volumes surrounding the
staining target. This should help improve the true positive hit
rate while also helping to identify proteins in the same cell
structure that may not be in actual molecular contact. Mean-
while, identification of new nuclear speckle proteins should lead
to improved structural and functional dissection of nuclear
speckles, as illustrated with our identification of the changes in
nuclear speckle size, shape, and nuclear distribution produced
after manipulating MFAP1 levels.
Materials and methods
Cell culture, plasmid constructs, and transfections
U2OS and Tig3 cells were cultured in DMEM (Thermo Fisher
Scientific) supplemented with 10% bovine growth serum (Hy-
clone). CHO cells were cultured in Ham’s F12 media (Thermo
Fisher Scientific) supplemented with FBS (MilliporeSigma).
Penicillin-streptomycin (Thermo Fisher Scientific) was added to
all growth media, and cells were incubated in a 37°C humidified
incubator with 5% CO2. For DNA cloning, total RNA was ex-
tracted from U2OS cells using RNeasy kit (Qiagen). Approxi-
mately 1 µg total RNA was reverse transcribed into cDNA using
the Protoscript First Strand cDNA Synthesis Kit (New England
Biolabs). Unless otherwise stated, all GFP constructs were
cloned, using a PCR-based strategy, into the Clonetech pGFP-C1
backbone (Clonetech). All mCherry constructs were based on the
pmCherry-C1 backbone (Clonetech). pCIBN-hTRF2-tagRFP-T
was a gift from Karsten Rippe (University of Heidelberg, Hei-
delberg, Germany; plasmid 103812; Addgene). TagRFP-MFAP1
was modified from GFP-MFAP1 construct by replacing the GFP
open reading frame with TagRFP open reading frame using AgeI
and XhoI restriction sites. All constructs were sequenced and
verified before use. DNA constructs were transfected using the
Lipofectamine 2000 Transfection Reagent (Thermo Fisher Sci-
entific) and following the manufacturer’s instructions with
minor modifications. Briefly, cells in 6-well plates were
transfected with 0.5 µg plasmid DNA, and 24-well plates were
transfected with 0.1 µg plasmid DNA. Transfection complexes
were prepared by separately diluting plasmid DNA and Lip-
ofectamine 2000 reagent in appropriate volumes of OptiMEM
(Thermo Fisher Scientific). Diluted DNA and Lipofectamine
2000 transfection reagent were mixed and incubated for 5 min
at room temperature to form transfection mix. Transfection mix
was added onto cells in complete growth media, and cells were
incubated at 37°C and either analyzed after 24 h or, for long-term
culturing, drugs for selection were added.
Antibodies
The following primary antibodies were used in this study: anti-
CENPA (AB13939; Abcam), anti-SC35 (S4045; MilliporeSigma),
anti-MFAP1 (HPA042370; MilliporeSigma), anti-SRRM2 (PA5-
68009; Thermo Fisher Scientific), anti-ZNF207 (HPA017013;
MilliporeSigma), anti-HP1α (H2164; MilliporeSigma), anti-β
Tubulin (AB18207; Abcam), anti-FITC (200-002-037; Jackson
ImmunoResearch), custom-made anti-SON (Chen et al., 2018;
PACIFIC10700; Pacific Immunology), anti-Nucleophosmin (AB86712;
Abcam), anti-nucleolin (AB70493; Abcam), anti-Coilin (Ab87913;
Abcam), and anti-PRPF38A (PA5-62730; Thermo Fisher Scientific).
Secondary antibodies used were goat anti-mouse HRP (115-035-062;
Jackson ImmunoResearch), goat anti-rabbit HRP (111-035-144; Jack-
son ImmunoResearch), goat anti-mouse FITC (111-095-144; Jackson
ImmunoResearch), and goat anti-rabbit Texas red (115–075-146;
Jackson ImmunoResearch).
RNA interference
The following RNA duplexes were used for RNAi: ON-
TARGETplus nontargeting control siRNA #1 (D-001810-01-05;
Dharmacon), human MFAP1 (D-020071-03-0002: 59-AAGUGA
AGGUAAAGCGUUA-39; Dharmacon), human MFAP1 39 UTR (D-
020071-17-0002: 59-GGAGUAAUAUACCCGGAAA-39; Dharma-
con), mouse Mfap1a (D-063511-01-0002: 59-UAAGAAAGCUAA
GGAACAA-39; Dharmacon), human SRRM2 (D-015368-01: 59-
GAGCAAAUCUCAAACAUCA-39; D-015368-03: 59-AAAGAAUGU
CCACAAGUA-39; D-015368-05: 59-GGAAUGAAAGAUAUACCUA-
39; D-015368-006: 59-GACAGCAAAUCUCGACUAU-39; Dharma-
con), and human PRPF38A (D-014833-02-0002: 59-CGAUAA
AGCCAUGGAGUUA-39; Dharmacon). ZNF207 siRNA oligo was
used in a previous study (Jiang et al., 2015; 59-GCCUGCUACACU
UACAACAACUAU-39; Invitrogen). The sequence targeting the
mouse Mfap1a (D-063511-01-0002) exactly matches the region
in CHO cells and was thus used to knock down Mfap1 in CHO
cells. All siRNAs were transfected at a concentration of 10
nM using the Lipofectamine RNAiMax transfection reagent
(Thermo Fisher Scientific) and following the manufacturer’s
directions. Briefly, cells were seeded overnight, and transfection
complexes were prepared by separately diluting 10 nM siRNA
and appropriate volume of Lipofectamine RNAiMAX transfec-
tion reagent in OptiMEM. Diluted siRNA and RNAiMAX trans-
fection reagent were mixed and incubated for 5 min to form
transfection complexes. Transfection complexes were added
onto cells in complete growthmedia and cells were incubated for
72–96 h before cells were analyzed.Western blotting was used to
determine KD of proteins.
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Chemical treatments
The following chemical inhibitors were used in this study to
inhibit RNA pol II transcription: 5,6-dichloro-1-β-D-ribofur-
anosylbenzimidazole (DRB; D1916) was purchased from Milli-
poreSigma and α-amanitin (CAS 23109–05-9) was purchased
from Santa Cruz Biotechnology. All inhibitors were dissolved in
DMSO and used at the following final concentrations: DRB, 50 µg/
ml; α-amanitin, 10 µg/ml. For washout experiments with DRB,
cells were incubated with DRB for 2 h before cells were rinsed at
least three times with prewarmed complete growth media.
Immunostaining, microscopy, and image processing
Cells were seeded on coverslips in appropriate wells, and where
indicated, cells were treated before fixing with either 100% ice-
cold methanol at −20°C or 4% PFA (MilliporeSigma) in PBS at
room temperature. All fixations were for 20 min, and cells were
rinsed at least three times with PBS after fixation. PFA-fixed
cells were permeabilized with 0.1% Triton X-100 (Milli-
poreSigma) for 30 min at room temperature. Cells were blocked
for 1 h at room temperature in blocking buffer consisting of 5%
goat serum (MilliporeSigma) and 0.1% Triton X-100 in PBS be-
fore incubation with appropriate dilution of primary antibody,
in blocking buffer, for 1 h at room temperature or overnight at
+4°C. Cells were rinsed three times with wash buffer (0.1%
Trition X-100 in PBS) and incubated at room temperature with
fluorescent-conjugated secondary antibody diluted in blocking
buffer. After 1 h, cells were rinsed three times with wash buffer
and mounted using Mowiol (Calbiochem) containing 1,4-dia-
zabicyclo [2.2.2] octane (MilliporeSigma). DAPI (Millipore-
Sigma) was added to stain DNA in the nucleus. All images of
fixed cells were acquired using a DeltaVision microscope
equipped with a Xenon lamp, 60× 1.4 NA oil-immersion objec-
tive lens (Olympus) and CoolSNAP HQ charge-coupled device
camera (Roper Scientific) and the SoftWorx imaging software
(GE Healthcare). Where necessary, images were deconvolved
and projected into 2D using the maximum intensity algorithm in
SoftWorx imaging software. Where applicable, images were
exported into TIFF and processed using FIJI (ImageJ). Nuclear
speckle areas were also measured using FIJI, and time-lapse
videos were converted into MP4 with VLC media player.
Time-lapse microscopy
For live imaging, cells were seeded in 35-cm glass-bottom dishes
(MatTek Corporation) and treated as required. Imaging was
performed at 37°C in 5% CO2 chamber attached to a V3 OMX
microscope (GE Healthcare) equipped with a 100× 1.4 NA oil-
immersion objective (Olympus) and an electron multiplying
charge-coupled device camera (Photometrics). We collected
image stacks, deconvolved and projected into 2D using the
maximum intensity projection algorithm in the SoftWorx soft-
ware (GE Healthcare). Where necessary, DNA was stained using
the SiR-DNA kit (Cytoskeleton).
Western blotting
Proteins were resolved in 8% or 10% SDS-PAGE gels and trans-
ferred into nitrocellulose membranes (Bio Rad laboratories).
Membranes were blocked for 1 h at room temperature with
blocking buffer (5% nonfat milk, 0.1% Tween 20 in PBS) before
membranes were incubated, overnight at 4°C, with gentle
rocking, in primary antibodies diluted in blocking buffer.
Membranes were washed three times 10 min in wash buffer
(0.1% Tween 20 in PBS) at room temperature before membranes
were incubated with HRP-conjugated secondary antibodies at
room temperature for 1 h in blocking buffer. Membranes were
washed 3 × 10 min in wash buffer, incubated in Immobilon
Western HRP Substrate (Millipore) for 5 min before protein
bands were detected using iBright Imaging System (Thermo
Fisher Scientific). Tubulin was detected as the loading control.
Tyramide-FITC conjugation and TSA reaction
While tyramide-fluorescein (FITC) is commercially available (for
example, PerkinElmer, # NEL741001KT), we instead performed
tyramide-fluorescein conjugation as previously described
(Hopman et al., 1998). Fluorescein-NHS ester was purchased
from Thermo Fisher Scientific; and tyramine hydrochloride
(tyramide), dimethyl formamide (DMF), and triethylamine were
purchased fromMilliporeSigma. Fluorescein-NHS stock solution
(21 mM) was prepared in DMF. Tyramide-hydrochloride (HCL)
stock solution (58 mM) was prepared in DMF containing 71 mM
triethylamine. Equal amounts of fluorescein-NHS in the
fluorescein-NHS stock solution and tyramide-HCL in the
tyramide-HCL stock solution were combined and the mixture
was incubated in the dark for 2 h at room temperature. The
conjugated tyramide-FITC was diluted to 1 mg/ml with ethanol
and stored in dark at −20°C. The TSA protocol wasmodified from
Chen et al. (2018). U2OS cells were grown to 90% confluency in
15-cm cell culture dishes. Cells were fixed with 1% PFA in PBS at
room temperature for 20 min. Cells were rinsed for 10 min with
0.25 M glycine to quench free aldehydes and further rinsed with
PBS, scrapped using cell lifter (Thermo Fisher Scientific), and
transferred into a 1.5-ml tube for subsequent processing. From
this point on, all washes were done by suspending cells in 1 ml
PBST (0.1% Triton X-100 in PBS) followed by 3-min centrifuga-
tion at 3,000 rpm in room temperature. Cells were per-
meabilized with 0.5% Triton X-100 for 30 min at room
temperature under gentle rotation. Cells were washed three
times and suspended in 1.5% H2O2 (MilliporeSigma) and incu-
bated at room temperature, with gentle rotation, to quench
the endogenous peroxidase. After 1 h, cells were rinsed three
times with PBST and blocked for 1 h at room temperature in
blocking buffer (5% goat serum in PBST). Typically, cells were
suspended in primary antibodies diluted in 1 ml blocking
buffer at 2 µg per 20 million cells and incubated overnight at
4°C with gentle rotation. Cells were rinsed three times with
PBST and suspended in HRP-conjugated secondary antibody
at 2 µg per 20 million cells in blocking buffer and incubated
overnight at 4°C. Cells were rinsed three times with PBST and
suspended in TSA reaction buffer (0.1 µg/ml tyramide-
fluorescein in PBS and 0.015% H2O2) for 10 min before cells
were rinsed three times with PBST. To verify the TSA labeling
reaction, ∼5 µl cell pellet was mounted on cover glasses, using
Mowiol 1,4-diazabicyclo [2.2.2] octane, for light microscopy.
Approximately 150 million cells were processed per antibody
for each MS run.
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Pull-down of tyramide-FITC–labeled proteins
To affinity purify and enrich fluorescein (FITC)–labeled pro-
teins, we used the Pierce Direct IP kit (#26148; Thermo Fisher
Scientific) to couple anti-FITC antibody to agarose beads fol-
lowing the manufacturer’s instructions with some mod-
ifications. We used 10 µg anti-FITC antibody and 25 µl Pierce
AminoLink Plus Coupling Resin slurry in the coupling reaction.
After the coupling reaction, columns containing anti-FITC cou-
pled beads were either directly used for the pull-down of FITC-
labeled proteins or stored at +4°C in Pierce coupling buffer with
0.02% sodium azide until needed. For the pull-down of FITC-
labeled proteins, after TSA reaction, cells were rinsed once with
coupling buffer and suspended in 500 µl ice-cold Pierce lysis
buffer supplemented with protease inhibitor cocktail (Milli-
poreSigma) and DNase I (New England Biolabs). Cell suspension
was incubated on ice for 30 min and vortexed every 5–10 min.
Cell suspension was passed through a 25G needle (BD Bio-
sciences) attached to a 1-ml syringe (BD Biosciences) to break
larger cell clumps. Cells were sonicated at 4°C using the Bio-
ruptor Pico sonicator (Diagenode) to obtain clear or evenly
cloudy lysates. Lysates were centrifuged at 16,000 rpm for
10 min at 4°C to pellet cell debris. Equal amounts of the super-
natants, as determined using the BCA Assay Kit (Thermo Fisher
Scientific) from either anti-SC35 TSA or anti-CENPA TSA re-
action, were cleared for 1 h at 4°C using Pierce Control Agarose
Resin. Cleared lysates were loaded onto Pierce Spin Columns
containing anti-FITC–coupled Pierce AminoLink plus coupling
resin and incubated overnight at +4°C with gentle end-over-end
rotation. Beads were washed three times with ice-cold wash
buffer supplemented with protease inhibitor and once with
100 µl Pierce conditioning buffer. Beads were eluted in a total
volume of 50 µl of Pierce elution buffer. Approximately 20 µl
eluate was boiled in SDS-PAGE sample loading buffer for 10 min
at 100°C and saved for Western blotting; the other 30 µl was
saved for in-solution trypsin digestion and MS.
MS
Eluted proteins were reduced with Tris (2-carboxyethyl) phos-
phine (MilliporeSigma), alkylated with Iodoacetamide (Milli-
poreSigma), and digested with Lys C/Trypsin (Thermo Fisher
Scientific) overnight. The digested samples were desalted by
HPLC using an Optimize Technologies C8 microtrap. Samples
were resuspended in 0.2% formic acid and directly loaded onto a
PicoFrit column (NewObjective) packed in house with ReproSil-
Pur C18AQ 1.9 µm resin (120 A˚ pore size; Dr.Maisch GmBH). The
25 cm × 50 µm ID columnwas heated to 60°C. The peptides were
separated with a 120-min gradient at a flow rate of 220 nl/min
using a nanoflow LC system, EASY-nLC 1200, (Thermo Fisher
Scientific). The gradient was as follows: 2–6% solvent B (7.5
min), 6–25% B (82.5 min), and 25–40% B (30 min), and 40–100%
B (9 min). Solvent A consisted of 97.8% H2O, 2% acetonitrile, and
0.2% formic acid and solvent B consisted of 19.8% H2O, 80%
acetonitrile, and 0.2% formic acid. The separated peptides were
ionized by a Nanospray Flex ion source and subjected to MS/MS
analysis using a QExactive HF Orbitrap mass spectrometer
(Thermo Fisher Scientific). The QExactive HF Orbitrap was
operated in data-dependent mode with the Tune (version 2.7
SP1build 2659) instrument control software. Spray voltage was
set to 2.5 kV, S-lens RF level at 50, and heated capillary at 275°C.
Full scan resolution was set to 60,000 at m/z 200. Full scan
target was 3 × 106 with a maximum injection time of 15 ms. Mass
range was set to 300−1,650 m/z. For data-dependent MS2 scans,
the loop count was 12, target value was set at 105, and intensity
threshold was kept at 105. Isolation width was set at 1.2 m/z, and
a fixed first mass of 100 was used. Normalized collision energy
was set at 28. Peptide match was set to off, and isotope exclusion
was on. Data acquisition was controlled by Xcalibur (4.0.27.13).
LFQ of MS data
Raw data were analyzed using MaxQuant (version 1.6.5.0; Cox
and Mann, 2008). Spectra were searched against UniProt hu-
man entries (74,487 sequences) and a contaminant protein da-
tabase (247 sequences). A decoy database was used to establish
score thresholds to achieve a 1% protein and peptide false dis-
covery rate. Variable modifications searched were protein
N-terminal acetylation and methionine oxidation. Carbamido-
methylation was specified as a fixed modification of cysteine.
Trypsin was the specified digestion enzyme with up to two
missed cleavages allowed. LFQ and match-between-runs were
enabled (Cox et al., 2014).
Online supplemental material
Fig. S1 shows TSA labeling of proteins, including chemical
structure of tyramide-FITC, Western blots, and protein gels after
TSA labeling. Fig. S2 shows data analysis, functional annotation,
and validation of potential nuclear speckle proteins, including
analysis of MS data and demonstration of loss of ZNF207 and
MFAP1 from speckles after PFA fixation. Fig. S3 shows that
MFAP1 KD specifically increases nuclear speckle size. Fig. S4
shows nuclear distribution of MFAP1 relative to nuclear speck-
les as function of DRB treatment and also in mitosis. Table S1
shows MS data. Video 1 shows that nuclear speckles in MFAP1-
depleted cells relocate to nucleolar periphery after DRB treatment
(related to Fig. 3 F). Video 2 shows that GFP-MFAP1 segregates into
foci adjacent to nuclear speckles after DRB treatment. Video 3
shows that reversal of RNA pol II transcription inhibition results
in disappearance of MFAP1-positive droplet-like foci adjacent to
nuclear speckles (related to Fig. 4 E). Video 4 shows that reversal
of RNA pol II transcription inhibition results in disappearance of
GFP-PRPF38A droplet-like foci adjacent to nuclear speckles (re-
lated to Fig. 4 F). Video 5 shows that GFP-MFAP1 reenters nucleus
and forms droplet-like foci before reentry of SON protein and
nuclear speckle reassembly aftermitosis (related to Fig. 5 E). Video
6 shows that GFP-MFAP1 localizes and accumulates into foci in the
nucleus before complete chromatin decondensation (related to
Fig. 5 E).
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Figure S1. TSA labeling of proteins. (A) Chemical structure of tyramide-FITC and the labeling of proteins. (B) Western blot (WB) after TSA labeling with
either tyramide-biotin or tyramide-FITC. Cell lysate without TSA reaction and a TSA reaction without primary antibody were included as controls. (C) Gel
picture showing total protein staining of 0.5% of the input lysate after TSA reaction compared with 50% of the total proteins pulled down. (D) Western blot
comparing FITC-labeled proteins as in C.
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Figure S2. Data analysis, functional annotation, and validation of potential nuclear speckle proteins. (A) Scatter plot of the nuclear speckle versus
centromere ratio (SPK-CEN ratio) of proteins. (B) Bar chart showing the GO annotated biological processes of the top 250 proteins as sorted by the SPK-CEN-
Ratio. (C) Pie chart showing the GO annotated biological processes of the top 100 proteins as sorted by the SPK-CEN ratio. (D) Immunofluorescence of U2OS
cells costained with anti-MFAP1 or anti-ZNF207 (green) and SC35 (red) after PFA fixation. (E) Anti-SC35 immunostaining (red) of U2OS cells expressing GFP-
ZNF207 (green) and fixed with PFA shows loss of GFP-ZNF207 fluorescence after fixation. Scale bars: 10 µm.
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Figure S3. MFAP1 KD specifically increases nuclear speckle size. (A)Western blots showing RNAi depletion of the indicated proteins (SRRM2, ZNF207, or
PRPF38A) in U2OS cells. (B and C) Western blot showing the depletion of MFAP1 in Tig3 (B) or CHO (C) cells. Tubulin was detected as loading control.
(D) Representative anti-SON immunofluorescence images of U2OS cells following siRNA treatment as indicated. (E) Representative anti-SON and anti-SC35
coimmunostaining of U2OS cells transfected with control siRNA (siCTRL) or siRNA against SRRM2 (siSRRM2). (F and G) Anti-SON immunofluorescence images
of Tig3 cells (F) or CHO cells (G) after transfection with control siRNA (siCTRL) or siRNA against MFAP1 (siMFAP1). DNA (blue) was stained with DAPI. Scale
bars: 10 µm.
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Video 1. Nuclear speckles inMFAP1-depleted cells relocate to nucleolar periphery after DRB treatment. Time-lapse video of MFAP1-depleted U2OS cell
expressing GFP-ZNF207 nuclear speckle marker and treated with DRB. Arrow points to a nuclear speckle that moves to and then merges with nucleolar
periphery. After contacting the nucleolar periphery, the speckle flattens in shape and its contents appear to then spread out and partially encircle the nucleolar
periphery. Time (top left corner) in hours:minutes format.
Video 2. GFP-MFAP1 segregates into foci adjacent to nuclear speckles after DRB treatment. Time-lapse video of a U2OS cell coexpressing GFP-MFAP1
(green) and mCherry-SON (red) and treated with DRB. Time-lapse image acquisition started ∼15 min after DRB treatment. Arrowheads indicate GFP-MFAP1
foci next to nuclear speckles (red). Numbers at the top left are time points in hours:minutes format.
Video 3. Reversal of RNA pol II transcription inhibition results in disappearance of MFAP1-positive droplet-like foci adjacent to nuclear speckles.
Time-lapse video of a U2OS cell coexpressing GFP-MFAP1 (green) and mCherry-SON (red). Cells were treated for 2 h with DRB to induce MFAP1 foci and then
rinsed with complete growth media before imaging. Arrowheads indicate GFP-MFAP1 foci adjacent to nuclear speckles that partially disappear as GFP-MFAP1
reenters nuclear speckles. Time (top left) in hours:minutes format.
Figure S4. Nuclear speckle localization of MFAP1. (A) Immunofluorescence images of U2OS cells after SC35 and MFAP1 coimmunostaining following
treatment with either DMSO or DRB for 2 h. Cells were fixed with 100% methanol. (B) Representative immunofluorescence image of a mitotic U2OS cell after
SC35 and MFAP1 coimmunostaining following PFA fixation. DNA (blue) was stained with DAPI. Scale bars: 10 µm.
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Video 4. Reversal of RNA pol II transcription inhibition results in disappearance of GFP-PRPF38A droplet-like foci adjacent to nuclear speckles.
Time-lapse video of a U2OS cell coexpressing GFP-PRPF38A (green) and mCherry-SON (red). Cells were treated for 2 h with DRB to induce GFP-PRPF38A foci
and then rinsed with complete growth media before imaging. Arrowheads indicate GFP-PRPF38A foci that disappear as GFP-PRPF38A renters nuclear
speckles. Time (top left) in hours:minutes format.
Video 5. GFP-MFAP1 reenters nucleus and forms droplet-like foci before reentry of SON protein and nuclear speckle reassembly after mitosis. Time-
lapse video of a mitotic U2OS cell expressing GFP-MFAP1 (green) and mCherry-SON (red). Time points (top left corner) in hours:minutes format.
Video 6. GFP-MFAP1 localizes and accumulates into foci in the nucleus before complete chromatin decondensation. Time-lapse video of a mitotic
U2OS cell expressing GFP-MFAP1 (green). Arrowheads indicate GFP-MFAP1–positive foci. Numbers at top left are time points in the hours:minutes format.
DNA (red) was visualized with SiR-Hoechst.
Table S1 is provided online and shows MS data.
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